To maintain data integrity and safety, it is necessary to highlight and detect duplicate subjects in your clinical trials proactively. This is true for nearly all therapeutic indications and all phases of clinical trials research. Duplicate enrollment (over enrollment) is NOT just a healthy volunteer phase 1 issue. The global research subject database registry VCT data over the …
Duplicate subjects and preventable protocol violations can easily be prevented up-front at the time of screening using the global research subject database registry Verified Clinical Trials (VCT). The protections continue for the entire duration fo the study including the specific washout criteria. VCT has data that routinely demonstrates double digit preventable protocol violations. Professional research …
Duplicate subjects in clinical trials result in increased placebo rates and poor quality data. This is oftentimes the silent killer of your study. www.verifiedclinicaltrials.com (VCT) is the global research subject database registry that is utilized by countless sites and sponsors worldwide. Duplicate subjects in clinical trials cause safety and dat quality issues. They drive up the …
Duplicate subjects in clinical trials result in safety and data quality issues. The global Verified Clinical Trials research subject database registry system is used around the world to prevent duplicate subjects in clinical trials. Typical higher risk clinical trials can see double digit incidence rates of protocol violations that will be prevented by Verified Clinical …
